blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1372670

EP1372670 - CALOPOROSIDE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.03.2006
Database last updated on 03.09.2024
Most recent event   Tooltip02.11.2012Lapse of the patent in a contracting statepublished on 05.12.2012  [2012/49]
Applicant(s)For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[2004/01]
Inventor(s)01 / EDER, Claudia
Flörsheimer Strasse 7
65719 Hofheim / DE
02 / KURZ, Michael
Erlenweg 7
65719 Hofheim / DE
03 / BRÖNSTRUP, Mark
Musikantenweg 16
60316 Frankfurt / DE
04 / TOTI, Luigi
Frankfurter Strasse 5
65239 Hochheim / DE
 [2004/01]
Application number, filing date02719903.323.02.2002
[2004/01]
WO2002EP01916
Priority number, dateDE200111168209.03.2001         Original published format: DE 10111682
[2004/01]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO02072110
Date:19.09.2002
Language:DE
[2002/38]
Type: A1 Application with search report 
No.:EP1372670
Date:02.01.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 19.09.2002 takes the place of the publication of the European patent application.
[2004/01]
Type: B1 Patent specification 
No.:EP1372670
Date:25.05.2005
Language:DE
[2005/21]
Search report(s)International search report - published on:EP19.09.2002
ClassificationIPC:A61K31/70, A61P35/00, C07H13/06, C07H15/18
[2004/01]
CPC:
C07H15/203 (EP,US); C07H15/04 (KR); A61P35/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/01]
Extension statesAL09.10.2003
LT09.10.2003
LV09.10.2003
MK09.10.2003
RO09.10.2003
SI09.10.2003
TitleGerman:CALOPOROSID-DERIVATE, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG[2004/01]
English:CALOPOROSIDE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE[2004/01]
French:DERIVES DE CALOPOROSIDE, LEUR PROCEDE DE PRODUCTION ET LEUR UTILISATION[2004/01]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase09.10.2003National basic fee paid 
09.10.2003Designation fee(s) paid 
09.10.2003Examination fee paid 
Examination procedure26.09.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.10.2003Examination requested  [2004/01]
15.01.2004Despatch of a communication from the examining division (Time limit: M04)
17.05.2004Reply to a communication from the examining division
15.10.2004Communication of intention to grant the patent
25.02.2005Fee for grant paid
25.02.2005Fee for publishing/printing paid
Opposition(s)28.02.2006No opposition filed within time limit [2006/20]
Fees paidRenewal fee
01.03.2004Renewal fee patent year 03
28.02.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]  - WEBER W ET AL, "Caloporoside, a new inhibitor of phospholipases C from Caloporus dichrous (Fr.) Ryv.", THE JOURNAL OF ANTIBIOTICS. JAPAN NOV 1994, (199411), vol. 47, no. 11, ISSN 0021-8820, pages 1188 - 1194, XP001088232 [A] 1-15 * page 1191; figure 1 *
 [A]  - CRICH D ET AL, "Convergent, Stereoselective Synthesis of the Caloporoside Disaccharide", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19981217), vol. 39, no. 51, ISSN 0040-4039, pages 9339 - 9342, XP004144195 [A] 1-15 * page 9339; figures 1,2 *

DOI:   http://dx.doi.org/10.1016/S0040-4039(98)02159-5
 [A]  - FAENZA I ET AL, "A role for nuclear phospholipase Cbeta 1 in cell cycle control.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. UNITED STATES 29 SEP 2000, (20000929), vol. 275, no. 39, ISSN 0021-9258, pages 30520 - 30524, XP001088079 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1002/(SICI)1097-4636(199801)39:1<102::AID-JBM13>3.0.CO;2-H
 [A]  - HAJDÚCH M ET AL, "Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs.", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. UNITED STATES 1999, (1999), vol. 457, ISSN 0065-2598, pages 341 - 353, XP002201689 [A] 1-15 * abstract *
 [T]  - ORTEGA^A^B S ET AL, "Cyclin D-dependent kinases, INK4 inhibitors and cancer", BBA - REVIEWS ON CANCER, ELSEVIER SCIENCE BV, AMSTERDAM, NL, (20020314), vol. 1602, no. 1, ISSN 0304-419X, pages 73 - 87, XP004349034 [T] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0304-419X(02)00037-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.